ArticleJournal for immunotherapy of cancer2024

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Esperanza Esquinas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.